117 related articles for article (PubMed ID: 17919068)
21. Biliverdin reductase is a transporter of haem into the nucleus and is essential for regulation of HO-1 gene expression by haematin.
Tudor C; Lerner-Marmarosh N; Engelborghs Y; Gibbs PE; Maines MD
Biochem J; 2008 Aug; 413(3):405-16. PubMed ID: 18412543
[TBL] [Abstract][Full Text] [Related]
22. Overexpression of biliverdin reductase enhances resistance to chemotherapeutics.
Florczyk U; Golda S; Zieba A; Cisowski J; Jozkowicz A; Dulak J
Cancer Lett; 2011 Jan; 300(1):40-7. PubMed ID: 20934804
[TBL] [Abstract][Full Text] [Related]
23. Biliverdin reductase: more than a namesake - the reductase, its Peptide fragments, and biliverdin regulate activity of the three classes of protein kinase C.
Gibbs PE; Tudor C; Maines MD
Front Pharmacol; 2012; 3():31. PubMed ID: 22419908
[TBL] [Abstract][Full Text] [Related]
24. Biliverdin reductase: a target for cancer therapy?
Gibbs PE; Miralem T; Maines MD
Front Pharmacol; 2015; 6():119. PubMed ID: 26089799
[TBL] [Abstract][Full Text] [Related]
25. Old biliverdin reductase: links to insulin resistance and may be a novel therapeutic target.
Wu B; Liu X; Shen J
Med Hypotheses; 2008; 71(1):73-6. PubMed ID: 18395354
[TBL] [Abstract][Full Text] [Related]
26. Biliverdin reductase as a target in drug research and development: Facts and hypotheses.
Mancuso C
Free Radic Biol Med; 2021 Aug; 172():521-529. PubMed ID: 34224815
[TBL] [Abstract][Full Text] [Related]
27. The Janus face of the heme oxygenase/biliverdin reductase system in Alzheimer disease: it's time for reconciliation.
Barone E; Di Domenico F; Mancuso C; Butterfield DA
Neurobiol Dis; 2014 Feb; 62():144-59. PubMed ID: 24095978
[TBL] [Abstract][Full Text] [Related]
28. The use of synthetic linear tetrapyrroles to probe the verdin sites of human biliverdin-IXalpha reductase and human biliverdin-IXbeta reductase.
Franklin EM; Browne S; Horan AM; Inomata K; Hammam MA; Kinoshita H; Lamparter T; Golfis G; Mantle TJ
FEBS J; 2009 Aug; 276(16):4405-13. PubMed ID: 19614742
[TBL] [Abstract][Full Text] [Related]
29. Impairment of biliverdin reductase-A promotes brain insulin resistance in Alzheimer disease: A new paradigm.
Barone E; Di Domenico F; Cassano T; Arena A; Tramutola A; Lavecchia MA; Coccia R; Butterfield DA; Perluigi M
Free Radic Biol Med; 2016 Feb; 91():127-42. PubMed ID: 26698666
[TBL] [Abstract][Full Text] [Related]
30. Human biliverdin reductase is autophosphorylated, and phosphorylation is required for bilirubin formation.
Salim M; Brown-Kipphut BA; Maines MD
J Biol Chem; 2001 Apr; 276(14):10929-34. PubMed ID: 11278740
[TBL] [Abstract][Full Text] [Related]
31. Redox Functions of Heme Oxygenase-1 and Biliverdin Reductase in Diabetes.
Rochette L; Zeller M; Cottin Y; Vergely C
Trends Endocrinol Metab; 2018 Feb; 29(2):74-85. PubMed ID: 29249571
[TBL] [Abstract][Full Text] [Related]
32. Activation of biliverdin-IXalpha reductase by inorganic phosphate and related anions.
Franklin E; Browne S; Hayes J; Boland C; Dunne A; Elliot G; Mantle TJ
Biochem J; 2007 Jul; 405(1):61-7. PubMed ID: 17402939
[TBL] [Abstract][Full Text] [Related]
33. Crystal structure of rat biliverdin reductase.
Kikuchi A; Park SY; Miyatake H; Sun D; Sato M; Yoshida T; Shiro Y
Nat Struct Biol; 2001 Mar; 8(3):221-5. PubMed ID: 11224565
[TBL] [Abstract][Full Text] [Related]
34. The oxidoreductase, biliverdin reductase, is induced in human renal carcinoma--pH and cofactor-specific increase in activity.
Maines MD; Mayer RD; Erturk E; Huang TJ; Disantagnese A
J Urol; 1999 Oct; 162(4):1467-72. PubMed ID: 10492239
[TBL] [Abstract][Full Text] [Related]
35. Repression of 5-aminolevulinate synthase gene by the potent tumor promoter, TPA, involves multiple signal transduction pathways.
Guberman AS; Scassa ME; Cánepa ET
Arch Biochem Biophys; 2005 Apr; 436(2):285-96. PubMed ID: 15797241
[TBL] [Abstract][Full Text] [Related]
36. Angiotensin II regulation of the Na+ pump involves the phosphatidylinositol-3 kinase and p42/44 mitogen-activated protein kinase signaling pathways in vascular smooth muscle cells.
Isenovic ER; Jacobs DB; Kedees MH; Sha Q; Milivojevic N; Kawakami K; Gick G; Sowers JR
Endocrinology; 2004 Mar; 145(3):1151-60. PubMed ID: 14630723
[TBL] [Abstract][Full Text] [Related]
37. Biliverdin reductase-A protein levels are reduced in type 2 diabetes and are associated with poor glycometabolic control.
Cimini FA; Barchetta I; Zuliani I; Pagnotta S; Bertoccini L; Dule S; Zampieri M; Reale A; Baroni MG; Cavallo MG; Barone E
Life Sci; 2021 Nov; 284():119913. PubMed ID: 34453944
[TBL] [Abstract][Full Text] [Related]
38. Biliverdin reductase deficiency triggers an endothelial-to-mesenchymal transition in human endothelial cells.
Klóska D; Kopacz A; Piechota-Polańczyk A; Neumayer C; Huk I; Dulak J; Józkowicz A; Grochot-Przęczek A
Arch Biochem Biophys; 2019 Dec; 678():108182. PubMed ID: 31704097
[TBL] [Abstract][Full Text] [Related]
39. Biliverdin Reductase-A Mediates the Beneficial Effects of Intranasal Insulin in Alzheimer Disease.
Barone E; Tramutola A; Triani F; Calcagnini S; Di Domenico F; Ripoli C; Gaetani S; Grassi C; Butterfield DA; Cassano T; Perluigi M
Mol Neurobiol; 2019 Apr; 56(4):2922-2943. PubMed ID: 30073505
[TBL] [Abstract][Full Text] [Related]
40. Multiple forms of biliverdin reductase: modification of the pattern of expression in rat liver by bromobenzene.
Huang TJ; Trakshel GM; Maines MD
Arch Biochem Biophys; 1989 May; 270(2):513-20. PubMed ID: 2705777
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
